RNA Leaders Investigator Registration

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Investor Registration form

13th-14th March 2024
Congress Center Basel

Terms and Conditions | Privacy Policy

Salutation (Mr., Mrs., Dr., etc.)

First Name *

Last Name *

Job title *

Company Name *

Business Email - The partnering system requires a personal corporate email address. We are unable to accept info@/admin@ or hotmail/gmail. *

Business Phone Number *

Business Address

City

State/Province *

Country/Region *

Postal/ZIP code

What type of investor are you?

Which stage of company(s) would you wish to engage? *

Pre-Seed

Seed

Series A

Series B

Series C+

Publicly Listed

Subsidiary

What areas of RNA are you most active/interested in? *

Antisense Technologies

Circular RNA

CRISPR, RNA and Gene Editing

Gene Therapy Approaches

MicroRNA

mRNA Therapeutics

mRNA Vaccines

Oligo Based Therapeutics

RNA Activation

RNA Cell Therapy

RNA Delivery

RNA Delivery Platforms

RNA Diagnostics

RNA Epigenetics

RNA Interference

RNA Manufacturing

Self-amplifying RNA

Small Molecules Targeting RNA

Splice Switching

tRNA

What stage(s) of company/product development interests you? *

Drug Discovery

Pre-Clinical

Phase I

Phase II

Phase III

Not Applicable

Min. investment size per round

Are you actively looking for syndication opportunities?

Please tick this box if you do not wish to receive news and promotions from Informa Connect about products and services relevant to me including information from our carefully selected partners. We will not share your details unless you agree to us doing so directly.

Please tick this box if you do not wish to hear from the RNA Leaders Europe sponsors and exhibitors about their products and services relevant to you.

Qualified investors can attend for free. Please check qualifying T&Cs before you register.

An investor who receives complimentary registration is expected to participate in the One-on-One Partnering, with at least two meetings secured through the system with life science companies.

LSX reserves the right, in its sole discretion, to make the determination of the proper classification of an investor or registrant. Depending on this classification, registration fees may be required.

If you have any questions please contact steph@lsxleaders.com